ReviewSeminars in interventional radiology2025
Advances in Thrombolytic Therapies for Venous Thromboembolism: A Review of Contemporary Approaches and Technologies.
Review in Seminars in interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New catheter-based technologies in the treatment of thrombolysis of venous thromboembolism have changed the landscape of the treatment of that disease spectrum. Traditional catheter-directed thrombolysis (CDT) typically involved placement of a lysis catheter and infusion of thrombolytic medications in the ICU setting for many hours, requiring frequent monitoring of fibrinogen, and titration of the thrombolytic agent based on patient-reported symptom improvement and standard vital signs. However, new devices and studies have shown effectiveness with significantly shorter infusion times and medication use, and have introduced features that may help to personalize therapy and help to preserve resources such as ICU bed allocation. This review examines the most recent advances in thrombolysis technology focusing on innovative devices and their clinical implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.